Bristol-Myers Squibb Company (BMY)
  • Россия
  • Украина

Bristol-Myers Squibb Company (BMY)

Contact Details

345 Park Ave Bsmt Lc3, New York, New York, USA 10154-0028
(212) 546-4000
345 Park Ave Bsmt Lc3, New York, New York, USA 10154-0028

General Information

Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions.

Contact Information

Phone(212) 546-4000
Customer Service Phone(800) 332-2056
Fax(212) 546-4390
Website 1
Thomson Reuters PermID4295903619


NamePositionTotal Annual CompensationYearPercent Change in Compensation
Lamberto AndreottiCEO$27,062,382201429.8%
Mr. Charles A. BancroftExecutive VP and CFO$12,054,284201453.0%
Mr. Francis M CussExecutive VP and Chief Scientific Officer$7,078,981201490.3%
Giovanni CaforioCOO$7,245,1782014119.4%
Sandra LeungGeneral Counsel, Secretary and Executive VP$8,054,805201467.2%

Corporate Data


  • Pharmaceutical Preparation Manufacturing
  • Dry, Condensed, and Evaporated Dairy Product Manufacturing

SIC Industries

  • Pharmaceutical Preparations
  • Baby Formulas

Company Size

Sales Volume$16.6 billion


Ticker SymbolBMY
ExchangeNew York Stock Exchange (NYSE)
Type of EntityFor Profit Organization
Type of OwnershipNot Tax Exempt Corporate Entity
Other CategorizationsManufacturer of Goods
Year Founded1887


Previous Close66.07
Bid65.86 x 100
Ask66.31 x 100
Day`s Range65.77 - 66.49
52-Week Range57.3 - 70.71
Average Volume (1M)6,224,039
Forward P/E27.58x
Trailing P/E32.87x
Market Cap.$110,511 Million
Dividend & Yield1.52 (2.3%)
Last Dividend Amount0.37
1y Target Price Est.67.2


Period EndingDec. 31, 2015Sep. 30, 2015Jun. 30, 2015Mar. 31, 2015
Total Revenue4,287,0004,069,0004,163,0004,041,000
Cost of Revenue952,0001,097,0001,013,000847,000
Gross Profit3,335,0002,972,0003,150,0003,194,000
Research Development1,916,0001,132,0001,856,0001,016,000
Selling General and Administrative1,501,0001,176,0001,135,0001,029,000
Depreciation and Amortization----
Other Operating Expenses328,000(323,000)107,000(299,000)
Total Operating Expenses4,697,0003,082,0004,111,0002,593,000
Other Income/Expenses Net----
Earnings Before Interest and Taxes(410,000)987,00052,0001,448,000
Interest Expense----
Income Before Tax(410,000)987,00052,0001,448,000
Income Tax Expense(222,000)257,000162,000249,000
Minority Interest----
Net Income from Continuing Ops(188,000)730,000(110,000)1,199,000
Discontinued Operations----
Extraordinary Items----
Effect of Accounting Changes----
Other Items(9,000)(24,000)(20,000)(13,000)
Net Income(197,000)706,000(130,000)1,186,000
Preferred Stock and Other Adjustments----
Net Income Applicable to Common Shares(197,000)706,000(130,000)1,186,000